Clinical Trials in Pittsburgh

Showing 14081-14100 of 21,047 trials

Non Invasive Blood Test To Diagnose Acute Rejection After Kidney Transplantation

NCT02424227

This is a prospective, multicenter, observational study of kidney transplant subjects where blood specimens, intended for dd-cfDNA and other future research purposes, will be drawn after transplant

Kidney Transplant Recipients

CareDx401 participantsStarted Apr 2015

Birmingham, Alabama, United States • Los Angeles, California, United States • Los Angeles, California, United States +11 more locations

COMPLETEDPhase 256 miles

Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes"

NCT02671461

The purpose of this study is to determine whether BMS-986141 is effective in reducing the recurrence of stroke in people who recently had a stroke, or a transient ischemic attack (known as a TIA or "mini stroke") and are receiving acetylsalicylic acid (also known as aspirin or ASA) to treat the stroke or TIA.

Thrombosis

Bristol-Myers Squibb16 participantsStarted Apr 2016

Phoenix, Arizona, United States • Newport Beach, California, United States • Newark, Delaware, United States +30 more locations

Non Invasive Blood Test To Diagnose Acute Rejection After Kidney Transplantation

Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes"

Find Trials by Condition in Pittsburgh

Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab

A Study of SC-005 in Subjects With Triple Negative Breast Cancer (TNBC)

A Long-Term Safety Study of ALKS 5461

Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors

Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia

Rollover Study for Continuing Valbenazine (NBI-98854) Administration for the Treatment of Tardive Dyskinesia

Study Evaluating CMC-544 In B-Cell Non-Hodgkin's Lymphoma

A Study to Assess the Effect of Ticagrelor in Reducing the Number of Days With Pain in Patients With Sickle Cell Disease

Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer

A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women

Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis

Remote Ischemic Preconditioning in Neurological Death Organ Donors

Akt Inhibitor MK2206 in Treating Patients With Advanced Breast Cancer

Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using Placebo

A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic Cancer

Study Of The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Retrospective Observational Study Investigating Fluciclovine (18F) (FACBC)